Substituted Pyrazolopyridopyridazines as Orally Bioavailable Potent and Selective PDE5 Inhibitors:  Potential Agents for Treatment of Erectile Dysfunction

Guixue Yu(Bristol-Myers Squibb (United States)), John E. Macor(Bristol-Myers Squibb (United States)), Andrew Henwood(Bristol-Myers Squibb (United States)), William G. Humphrey(Bristol-Myers Squibb (United States)), Helen J. Mason(Bristol-Myers Squibb (United States)), Ronald Pongrac(Bristol-Myers Squibb (United States)), Rongan Zhang(Bristol-Myers Squibb (United States)), Bin He(Guiyang Medical University), Ximao Wu(Bristol-Myers Squibb (United States)), Pam Ferrer(Bristol-Myers Squibb (United States)), Bruce Beyer(Bristol-Myers Squibb (United States)), Jian Wang(Bristol-Myers Squibb (United States)), Saeho Chong(Alnylam Pharmaceuticals (United States)), John Krupinski(Bristol-Myers Squibb (United States)), Leonard P. Adam(Bristol-Myers Squibb (United States)), Laurie Seliger(Bristol-Myers Squibb (United States)), Diane E. Normandin(Bristol-Myers Squibb (United States))
Journal of Medicinal Chemistry
January 8, 2003
10.1021/jm0256068
Cited by 38

Related Papers

Sirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase
|Science|2011|1.4k
SIRT6 regulates TNF-α secretion through hydrolysis of long-chain fatty acyl lysine
|Nature|2013|706
Overview of lethal human coronaviruses
|Signal Transduction and Targeted Therapy|2020|312
Locus coeruleus cellular and molecular pathology during the progression of Alzheimer’s disease
|Acta Neuropathologica Communications|2017|306
Identification of a cellularly active SIRT6 allosteric activator
|Nature Chemical Biology|2018|272